Table 2 Baseline demographics and clinical characteristics
All (n = 140) | VESD group (n = 69) | Control group (n = 71) | p | |
|---|---|---|---|---|
Age (years) | ||||
Mean (SD) | 74.1 (11.8) | 75.5 (11.1) | 72.7 (12.4) | 0.17 |
Median (IQR) | 76 (68–82.75) | 78 (69.5–84) | 75 (65–82) | |
Male (%) | 86 (61.4) | 42 (60.9) | 44 (62) | 0.01 |
Length of hospital stay (days) | ||||
Mean (SD) | 12.8 (7.7) | 11.8 (6.7) | 13.8 (8.4) | 0.17 |
Median (IQR) | 11.0 (8–16) | 10.0 (8–15.5) | 12.0 (8–16) | |
Stroke subtype, n (%) | ||||
Ischemic infarct/ Intracerebral haemorrhage | 130 (92.8)/ 10 (7.1) | 66 (95.6)/ 3 (4.3) | 64 (90.1)/ 7 (9.9) | 0.22 |
Treatment, n (%) | ||||
Thrombolysis/Thrombectomy | 15 (10.7)/6 (4.3) | 6 (8.7/4 (4.3)) | 9 (12.7)/3 (4.2) | |
NIHSSa, Median (IQR) | 2 (0–4), n = 139 | 2 (1–4.5) | 3 (1–5.25), n = 70 | 0.02 |
BIa, Median (IQR) | 80 (65–90), n = 139 | 82.5 (65–90), n = 68 | 80 (65–90) | |
MoCAa, Median (IQR) | 22 (19–26), n = 105 | 23 (20–26), n = 57 | 22 (18–25.7), n = 48 | 0.05 |
HADS-A Median (IQR) | 4 (1–8), n = 134 | 4 (1–8), n = 63 | 4 (1–8) | 0.22 |
HADS-D Median (IQR) | 3 (1–7), n = 134 | 3 (1–6), n = 63 | 3 (1–7) | 0.53 |
mRS Median (IQR) | 2 (2–3), n = 134 | 2 (2–3), n = 63 | 2 (2–3) | 0.14 |